California State Teachers Retirement System Bio Atla, Inc. Transaction History

California State Teachers Retirement System

$84.1 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.88 - $3.46 $5,326 - $9,802	-2,833 Reduced 38.91%	4,447 $15,000
Q4 2023 Feb 13, 2024	SELL	$1.27 - $3.18 $3,149 - $7,886	-2,480 Reduced 25.41%	7,280 $17,000
Q3 2023 Nov 14, 2023	SELL	$1.7 - $3.07 $8,421 - $15,208	-4,954 Reduced 33.67%	9,760 $16,000
Q2 2023 Aug 21, 2023	BUY	$2.83 - $3.87 $41,640 - $56,943	14,714 New	14,714 $44,000
Q2 2022 Aug 15, 2022	SELL	$2.13 - $5.38 $51,710 - $130,610	-24,277 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.38 - $18.78 $2,119 - $9,089	-484 Reduced 1.95%	24,277 $121,000
Q4 2021 Feb 15, 2022	BUY	$19.0 - $30.95 $10,982 - $17,889	578 Added 2.39%	24,761 $486,000
Q3 2021 Nov 15, 2021	BUY	$29.44 - $43.74 $216,943 - $322,320	7,369 Added 43.83%	24,183 $712,000
Q2 2021 Aug 16, 2021	SELL	$38.07 - $56.17 $24,935 - $36,791	-655 Reduced 3.75%	16,814 $713,000
Q1 2021 May 18, 2021	BUY	$32.41 - $70.91 $566,170 - $1.24 Million	17,469 New	17,469 $888,000

Others Institutions Holding BCAB

# of Institutions

Shares Held

17.3M

Call Options Held

500

Put Options Held

33.5K

Israel Englander Millennium Management LLC | New York, Ny

2.66M
Shares

$4.57 Million
0.0% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

2.52M
Shares

$4.33 Million
0.38% of portfolio
Vanguard Group Inc Valley Forge, PA

1.89M
Shares

$3.24 Million
0.0% of portfolio
Morgan Stanley New York, NY

1.86M
Shares

$3.2 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

874K
Shares

$1.5 Million
0.13% of portfolio

View Full List

About BioAtla, Inc.

Ticker BCAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,304,100
Market Cap $62.4M
Description
BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...

More about BCAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account